Siamab Therapeutics, Inc.

Whatever the prevailing winds are in biopharma M&A, privately held Boehringer Ingelheim GMBH ’s deal-making approach will remain centered on early-stage collaborations to bolster its therapeutic focu

IN VITRO DIAGNOSTICS Financings CareDx Inc. Molecular diagnostics firm CareDx Inc. netted $18.8mm through the follow-on public offering of 4.99mm common shares (including full exercise of the over

Investigating the potential of carbohydrate antibodies in cancer immunotherapy is an “under-attacked” area, Siamab Therapeutics Inc. CEO Jeff Behrens says, and he thinks his company now has import

Company Changes BARR , John To: Angiotech Pharmaceuticals Inc. , CEO (October) From: Bausch & Lomb Inc., EVP, Pres., Global Surgical Phone: 604-221-7676 BARTHELEMY , Nicolas To: bioTheranos